OBI Pharma, Inc. is a Taiwan-based company principally engaged in the development of new pharmaceuticals. The Company mainly operates its businesses through the research and development of novel cancer and infectious disease therapies.
OBI Pharma, Inc. and Odeon Therapeutic, the biopharma companies, have entered into an exclusive license agreement whereby OBI grants rights of OBI-999, a novel...